启迪药业(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000590 启迪药业

已收盘 07-05 15:00:00

{"stockData":{"symbol":"000590","market":"SZ","secType":"STK","nameCN":"启迪药业","latestPrice":5.33,"timestamp":1720162998000,"preClose":5.12,"halted":0,"volume":4051600,"delay":0,"floatShares":239000000,"shares":239000000,"eps":0.0434,"marketStatus":"已收盘","marketStatusCode":5,"change":0.21,"latestTime":"07-05 15:00:00","open":5.12,"high":5.35,"low":5.02,"amount":21163300,"amplitude":0.0645,"askPrice":5.33,"askSize":168,"bidPrice":5.32,"bidSize":118,"shortable":0,"etf":0,"ttmEps":0.0434,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1720402200000},"adr":0,"adjPreClose":5.12,"symbolType":"stock","openAndCloseTimeList":[[1720143000000,1720150200000],[1720155600000,1720162800000]],"highLimit":5.63,"lowLimit":4.61,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":239471267,"pbRate":1.71,"roa":"--","roe":"--","epsLYR":0.1054,"committee":-0.093551,"marketValue":1276000000,"floatMarketCap":1276000000,"peRate":122.811058,"changeRate":0.041,"turnoverRate":0.0169,"status":0},"requestUrl":"/m/hq/s/000590/tweets","defaultTab":"tweets","newsList":[{"id":"2445047319","title":"6月24日启迪药业跌5.48%，北信瑞丰中国智造基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445047319","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445047319?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:26","pubTimestamp":1719217569,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日启迪药业跌5.48%创60日新低，收盘报5.17元，换手率1.65%，成交量3.94万手，成交额2063.36万元。重仓启迪药业的公募基金请见下表：根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为北信瑞丰中国智造。北信瑞丰中国智造目前规模为0.19亿元，最新净值1.178，较上一交易日上涨0.0%，近一年下跌25.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400020813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2443184646","title":"启迪药业新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2443184646","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443184646?lang=zh_cn&edition=full","pubTime":"2024-06-14 13:49","pubTimestamp":1718344163,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日启迪药业集团股份公司新提交1件商标注册申请。商标申请详情如下：今年以来启迪药业集团股份公司新申请注册商标8件，截止目前公司共持有注册商标107件，另有32件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400022153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"gpt_icon":0},{"id":"2441318610","title":"6月7日启迪药业涨5.17%，北信瑞丰中国智造基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2441318610","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441318610?lang=zh_cn&edition=full","pubTime":"2024-06-07 16:24","pubTimestamp":1717748669,"startTime":"0","endTime":"0","summary":"证券之星消息，6月7日启迪药业涨5.17%，收盘报5.7元，换手率2.55%，成交量6.11万手，成交额3463.07万元。重仓启迪药业的公募基金请见下表：根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为北信瑞丰中国智造。北信瑞丰中国智造目前规模为0.19亿元，最新净值1.203，较上一交易日上涨0.25%，近一年下跌20.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700030003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000590","BK0122"],"gpt_icon":0},{"id":"2439612080","title":"启迪药业：未来如有收并购等相关重大事项，公司将严格依照法律法规要求，及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2439612080","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439612080?lang=zh_cn&edition=full","pubTime":"2024-05-30 19:02","pubTimestamp":1717066957,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业05月30日在投资者关系平台上答复投资者关心的问题。“古汉”品牌得到市场及客户的高度认可，树立了良好的市场口碑，已被评为“中华老字号”。未来公司如有收并购等相关重大事项，将严格按照监管规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053000033707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000590","BK0122"],"gpt_icon":0},{"id":"2439518493","title":"启迪药业（000590）5月29日主力资金净买入37.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439518493","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439518493?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:23","pubTimestamp":1716967396,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月29日收盘，启迪药业报收于6.33元，下跌7.86%，换手率10.19%，成交量24.38万手，成交额1.56亿元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：启迪药业2024年一季报显示，公司主营收入7709.36万元，同比下降23.82%；归母净利润-828.43万元，同比下降225.81%；扣非净利润-936.01万元，同比下降287.85%；负债率38.09%，投资收益9.0万元，财务费用54.99万元，毛利率50.77%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052900025183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2438344355","title":"5月28日启迪药业跌6.53%，北信瑞丰中国智造基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2438344355","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438344355?lang=zh_cn&edition=full","pubTime":"2024-05-28 16:24","pubTimestamp":1716884684,"startTime":"0","endTime":"0","summary":"证券之星消息，5月28日启迪药业跌6.53%，收盘报6.87元，换手率14.5%，成交量34.71万手，成交额2.46亿元。重仓启迪药业的公募基金请见下表：根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为北信瑞丰中国智造。北信瑞丰中国智造目前规模为0.19亿元，最新净值1.251，较上一交易日上涨0.16%，近一年下跌16.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052800028930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000590","BK0122"],"gpt_icon":0},{"id":"2438874701","title":"5月27日启迪药业涨停分析：保健品，中药，医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2438874701","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438874701?lang=zh_cn&edition=full","pubTime":"2024-05-27 15:32","pubTimestamp":1716795178,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业涨停收盘，收盘价7.35元。该股于9点34分涨停，2次打开涨停，截止收盘封单资金为6335.7万元，占其流通市值3.6%。5月27日的资金流向数据方面，主力资金净流入2645.12万元，占总成交额20.03%，游资资金净流出922.2万元，占总成交额6.98%，散户资金净流出1722.92万元，占总成交额13.05%。近5日资金流向一览见下表：该股为保健品，中药，医药概念热股，当日保健品概念上涨1.23%，中药概念上涨0.89%，医药概念上涨0.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700012384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1574","09939","BK1161","BK1515","BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2438876739","title":"加大“大健康”产业布局，启迪药业涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2438876739","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438876739?lang=zh_cn&edition=full","pubTime":"2024-05-27 14:43","pubTimestamp":1716792230,"startTime":"0","endTime":"0","summary":"营业收入中，中药及保健品占比95.06%，其他占比4.94%。该公司在年报中称，2024年，为完成公司确定的战略目标，公司将进一步加大在“大健康”产业的布局，延伸在“大健康”领域产业链，加不断强内部管理，通过强化生产过程管控，推进精细化管理，加快公司智能制造、绿色制造转型升级，降低产品成本，加强品牌宣传推广力度与营销体系及营销队伍建设，向销售网络、品牌知名度和美誉度全国化迈进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.stockstar.com/SS2024052700010884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2438874841","title":"异动快报：启迪药业（000590）5月27日9点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2438874841","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438874841?lang=zh_cn&edition=full","pubTime":"2024-05-27 09:40","pubTimestamp":1716774058,"startTime":"0","endTime":"0","summary":"证券之星5月27日盘中消息，9点38分启迪药业触及涨停板。目前价格7.35，上涨10.03%。其所属行业中药目前上涨。该股为高校系，保健品，雄安新区概念热股，当日高校系概念上涨0.33%，保健品概念上涨0.18%，雄安新区概念上涨0.12%。5月24日的资金流向数据方面，主力资金净流入32.31万元，占总成交额1.65%，游资资金净流入102.29万元，占总成交额5.23%，散户资金净流出134.6万元，占总成交额6.88%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700002719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"gpt_icon":0},{"id":"2433327894","title":"启迪药业最新公告：衡阳市国资委拟无偿划转公司5.84%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433327894","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433327894?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:11","pubTimestamp":1715076672,"startTime":"0","endTime":"0","summary":"启迪药业公告，衡阳市国资委决定将其持有的本公司5.84%股份无偿划转给衡阳弘湘国有投资（控股）集团有限公司。本次国有股权无偿划转实施完成后，弘湘集团将持有本公司19.11%的股份。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700031202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"gpt_icon":0},{"id":"2433275969","title":"启迪药业：公司股东国有股权无偿划转","url":"https://stock-news.laohu8.com/highlight/detail?id=2433275969","media":"港股那点事","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433275969?lang=zh_cn&edition=full","pubTime":"2024-05-07 17:59","pubTimestamp":1715075940,"startTime":"0","endTime":"0","summary":"格隆汇5月7日｜启迪药业公告，衡阳市国资委决定将其持有的本公司13,988,705股的无限售条件股份（占公司总股本的5.84%）无偿划转给衡阳弘湘国有投资（控股）集团有限公司。本次国有股权无偿划转实施完成后，弘湘集团将持有本公司19.11%的股份。               \n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-07/doc-inaukzec1644861.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-07/doc-inaukzec1644861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","000590","BK0122"],"gpt_icon":0},{"id":"2430435512","title":"启迪药业（000590）4月26日主力资金净买入525.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430435512","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430435512?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:23","pubTimestamp":1714116196,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月26日收盘，启迪药业报收于6.26元，下跌4.57%，换手率4.78%，成交量11.45万手，成交额7094.99万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：启迪药业2024年一季报显示，公司主营收入7709.36万元，同比下降23.82%；归母净利润-828.43万元，同比下降225.81%；扣非净利润-936.01万元，同比下降287.85%；负债率38.09%，投资收益9.0万元，财务费用54.99万元，毛利率50.77%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600028612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2430405475","title":"启迪药业最新公告：一季度净利润亏损828.43万元 同比转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2430405475","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430405475?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:10","pubTimestamp":1714043433,"startTime":"0","endTime":"0","summary":"启迪药业披露一季度报告，公司2024年第一季度实现营业收入7709.36万元，同比下降23.82%；净利润亏损828.43万元，同比转亏。报告期内，主要受主营业务收入减少和管理费用增加的影响，净利润同比减少。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500039904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"gpt_icon":0},{"id":"2430178479","title":"启迪药业(000590.SZ)发布一季度业绩，净亏损828.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430178479","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430178479?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:39","pubTimestamp":1714037947,"startTime":"0","endTime":"0","summary":"智通财经APP讯，启迪药业(000590.SZ)发布2024年一季度报告，报告期内实现营业收入7709.36万元，同比下降23.82%。归属于上市公司股东净亏损828.43万元。归属于上市公司股东的扣除非经常性损益净亏损936.01万元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2422998556","title":"启迪药业(000590.SZ)发布2023年度业绩，净利润2524.68万元，增长39.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422998556","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422998556?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:49","pubTimestamp":1711540140,"startTime":"0","endTime":"0","summary":"启迪药业发布2023年年度报告，该公司营业收入为4.05亿元，同比增长15.44%。归属于上市公司股东的净利润为2524.68万元，同比增长39.41%。归属于上市公司股东的扣除非经常性损益的净亏损为465.05万元。基本每股收益为0.1054元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inapumws3212797.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inapumws3212797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000590"],"gpt_icon":0},{"id":"2403808390","title":"启迪药业拟溢价4倍收购名实药业55%股权 标的被指缺主打产品“二把手”带头反对","url":"https://stock-news.laohu8.com/highlight/detail?id=2403808390","media":"市场资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2403808390?lang=zh_cn&edition=full","pubTime":"2024-01-15 07:47","pubTimestamp":1705276020,"startTime":"0","endTime":"0","summary":"　　手头并不宽裕的情况下，启迪药业依然坚持高溢价收购。　　1月12日，启迪药业公告显示，公司拟以现金人民币1.41亿元的对价，收购名实药业55%股权。其中，倪小桥还是副董事长、党委书记，为公司“二把手”。　　倪小桥、唐婷认为，名实药业缺主打产品，未来市场核心竞争力弱。　　当前，启迪药业业绩并不理想，公司2023年前三季度净利润仅643.01万元，同比下滑59.04%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-01-15/doc-inacqcyi8266609.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-01-15/doc-inacqcyi8266609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","000590","BK0122"],"gpt_icon":0},{"id":"2402244894","title":"启迪药业(000590.SZ)拟对启迪化工(医药)科技园项目追加投资5326.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402244894","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2402244894?lang=zh_cn&edition=full","pubTime":"2024-01-11 21:00","pubTimestamp":1704978000,"startTime":"0","endTime":"0","summary":"启迪药业发布公告，2019年10月28日，公司第八届董事会临时会议审议通过了《关于全资子公司拟对外投资建设古汉医药科技园项目并签订项目框架协议的议案》，决定以自有资金及自筹资金投资9956.59万元建设古汉医药科技园项目，计划建设制剂车间、仓库、辅助设施用房、办公科研楼、污水处理设施等工程。因此，为保障项目建设顺利推进，拟在项目原总投资计划金额9956.59万元的基础上，按照设计概算金额增加投资5326.75万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-11/doc-inacemiy2185145.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-11/doc-inacemiy2185145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK0122","BK0239","000590","BK1515","BK1161","09939","159938"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-01-19","address":"湖南省衡阳市蒸湘区高新区杨柳路33号","stockEarnings":[{"period":"1week","weight":-0.0358},{"period":"1month","weight":-0.1278},{"period":"3month","weight":-0.3281},{"period":"6month","weight":-0.4995},{"period":"1year","weight":-0.4128},{"period":"ytd","weight":-0.4286}],"companyName":"启迪药业集团股份公司","boardCode":"AI0027","perCapita":"11326股","boardName":"医药制造业","registeredCapital":"23947万元","compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":-0.0432},{"period":"3month","weight":-0.0364},{"period":"6month","weight":0.0097},{"period":"1year","weight":-0.0823},{"period":"ytd","weight":-0.0058}],"survey":"　　启迪药业集团股份公司主营业务是研究、开发中国中药传统秘方、验方和西药制剂。公司始终致力于医药大健康领域的拓展深耕，产品涵盖中药、化药、保健食品三大板块，主要产品包括中成药、西药制剂以及药食同源保健食品。作为传统中、西药生产与销售的企业，品牌与品种优势突出，是湖南省主要的医药企业之一。公司具有现代化的生产设备，产品“古汉养生精”因其独特配方，曾被评为国家秘密技术项目品种和国家中药保护品种，产品质量被市场及客户高度认可，树立了较好的市场口碑。","serverTime":1720185439871,"listedPrice":6,"stockholders":"21135人(较上一季度减少1.28%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"启迪药业(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供启迪药业(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"启迪药业,000590,启迪药业股票,启迪药业股票老虎,启迪药业股票老虎国际,启迪药业行情,启迪药业股票行情,启迪药业股价,启迪药业股市,启迪药业股票价格,启迪药业股票交易,启迪药业股票购买,启迪药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"启迪药业(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供启迪药业(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}